OBJECTIVES: We investigated a cluster of tuberculosis (TB) cases among persons using methamphetamines in Snohomish County, Washington, to determine the extent of the outbreak, examine whether methamphetamine use contributed to TB transmission, and implement strategies to prevent further infections. METHODS: We screened contacts to find and treat persons with TB disease or infection. We then formed a multidisciplinary team to engage substance abuse services partners and implement outreach strategies including novel methods for finding contacts and a system of incentives and enablers to promote finding, screening, and treating patients with TB and their infected contacts. RESULTS: We diagnosed and completed treatment with 10 persons with TB disease. Eight of 9 adult patients and 67% of their adult contacts reported using methamphetamines. Of the 372 contacts, 319 (85.8%) were screened, 80 (25.1%) were infected, 71 (88.8%) started treatment for latent infection, and 57 (80.3%) completed treatment for latent infection. CONCLUSIONS: Collaborative approaches integrating TB control, outreach, incentives, and enablers resulted in high rates of treatment adherence and completion among patients and infected contacts. TB control programs should collaborate with substance abuse programs to address addiction, overcome substance abuse-related barriers to treatment, treat TB, and prevent ongoing transmission.
OBJECTIVES: We investigated a cluster of tuberculosis (TB) cases among persons using methamphetamines in Snohomish County, Washington, to determine the extent of the outbreak, examine whether methamphetamine use contributed to TB transmission, and implement strategies to prevent further infections. METHODS: We screened contacts to find and treat persons with TB disease or infection. We then formed a multidisciplinary team to engage substance abuse services partners and implement outreach strategies including novel methods for finding contacts and a system of incentives and enablers to promote finding, screening, and treating patients with TB and their infected contacts. RESULTS: We diagnosed and completed treatment with 10 persons with TB disease. Eight of 9 adult patients and 67% of their adult contacts reported using methamphetamines. Of the 372 contacts, 319 (85.8%) were screened, 80 (25.1%) were infected, 71 (88.8%) started treatment for latent infection, and 57 (80.3%) completed treatment for latent infection. CONCLUSIONS: Collaborative approaches integrating TB control, outreach, incentives, and enablers resulted in high rates of treatment adherence and completion among patients and infected contacts. TB control programs should collaborate with substance abuse programs to address addiction, overcome substance abuse-related barriers to treatment, treat TB, and prevent ongoing transmission.
Authors: D C Snyder; E A Paz; J C Mohle-Boetani; R Fallstad; R L Black; D P Chin Journal: Am J Respir Crit Care Med Date: 1999-07 Impact factor: 21.405
Authors: Supriya D Mahajan; Zihua Hu; Jessica L Reynolds; Ravikumar Aalinkeel; Stanley A Schwartz; Madhavan P N Nair Journal: Mol Diagn Ther Date: 2006 Impact factor: 4.074
Authors: Gordon Mansergh; David W Purcell; Ron Stall; Mary McFarlane; Salaam Semaan; Jo Valentine; Ronald Valdiserri Journal: Public Health Rep Date: 2006 Mar-Apr Impact factor: 2.792
Authors: John E Oeltmann; Eyal Oren; Maryam B Haddad; Linda k Lake; Theresa A Harrington; Kashef Ijaz; Masahiro Narita Journal: Emerg Infect Dis Date: 2006-07 Impact factor: 6.883
Authors: Lilit Aslanyan; Vaibhav V Ekhar; Carlos M DeLeon-Rodriguez; Luis R Martinez Journal: Int Immunopharmacol Date: 2017-05-25 Impact factor: 4.932
Authors: Nora D Volkow; Joanna S Fowler; Gene-Jack Wang; Elena Shumay; Frank Telang; Peter K Thanos; David Alexoff Journal: PLoS One Date: 2010-12-07 Impact factor: 3.240
Authors: Habibullah Peerzada; Jay A Gandhi; Allan J Guimaraes; Joshua D Nosanchuk; Luis R Martinez Journal: Immunobiology Date: 2013-02-27 Impact factor: 3.144
Authors: Emma B Shak; Anne Marie France; Lauren Cowan; Angela M Starks; Juliana Grant Journal: Public Health Rep Date: 2015 Nov-Dec Impact factor: 2.792
Authors: Patrick K Moonan; Smita Ghosh; John E Oeltmann; J Steven Kammerer; Lauren S Cowan; Thomas R Navin Journal: Emerg Infect Dis Date: 2012-03 Impact factor: 6.883